Sun Pharma shares fall over 2% after US drug-pricing deal
Sun Pharma shares fall over 2% after a US drug-pricing deal, paring three-session gains. Tariff relief is cited as cushioning the impact.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.